ERLOCIP 150MG 30'S
Form: Tablet
Pack Size: 30 Tablets
Marketed by: CIPLA LTD (CANCER CARE)
MRP: ₹9798.99
Erlocip 150mg by Cipla (erlotinib 150 mg, 30 tablets) is an EGFR tyrosine kinase inhibitor (targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for non-small cell lung cancer with activating EGFR mutations, and advanced pancreatic cancer together with gemcitabine. Schedule H: dispense only against a valid prescription. Counselling point: rash and diarrhoea are common; smoking lowers blood levels, so advise quitting.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.